Brain Navi win 2 MERITS from the prestigious Asia Pacific ICT Alliance Awards (APICTA) 2020-21
Brain Navi Biotechnology won 2 MERITS from the prestigious Asia Pacific ICT Alliance Awards (APICTA) 2020-21
BrainNavi Biotechnology is happy to announce that “Zero-Contact Medical Station” WIN Asia Pacific ICT Alliance Award ( APICTA ) 2020/21 (merit Award) from Inclusions: Healthcare & Wellbeing Category & Research and Development. Two Merits from 163 teams (excluded student teams), 16 countries around the APEC region.
Zero-contact Medical Station
Standardize the procedure of sample collection is to protect medical staff from the cross-infectious environments. It only takes less than 30 minutes, from nasal swabbing to generate the RT-PCR report. High accuracy with the gold standard, nasopharynx swab, to prevent the false negative. Zero-contact is essential for both medical staff and testing subjects.
1. Zero- Contact: Testing subject and medical staff are isolated in different safety zone so that no need to put on another protection while proceeding sample collecting or pipetting.
2. Large-scale Testing: The combination of Nasal Swab Robot and Roche Liat system, the station can generate the PCR report in 30 mins.
3. Procedure Standardize: For medical staff, Lower the learning curves of the procedure, they are capable to do more than just sample collection.
4. High Accuracy: With Brain Navi Nasal Swab Robot, customize nasopharynx depth of each testing subject can lower the false-negative result.
The Asia Pacific ICT Alliance Awards (APICTA Awards) is an international awards program organized by APICTA, which aims to increase ICT awareness in the community and assist in bridging the digital divide. By providing networking and product benchmarking opportunities to ICT innovators and entrepreneurs in the region, the program is designed to stimulate ICT innovation and creativity, promote economic and trade relations, facilitate technology transfer, and offer business matching opportunities via exposure to venture capitalists and investors.